Fake Weight Loss Injections: The UK Mounjaro Crisis
- Juvenology Clinic
- 3 days ago
- 9 min read
I want to talk about something that has been weighing on me.
In May 2025, a 53-year-old woman called Karen McGonigal died after receiving weight loss injections at a beauty salon in Salford. She was charged £20 a shot. She was told it was Mounjaro. It wasn't. Four days after her final injection she was in intensive care. Two days later, her family made the decision to switch off life support.
Her daughters have since campaigned for tighter regulation. They met the Health Secretary in February 2026. Karen's story deserves to be heard far beyond the news cycle it briefly occupied.
I am writing this because patients who are curious about GLP-1 weight loss injections, Mounjaro, Wegovy, Ozempic, deserve an honest clinical picture of what is actually happening in the grey market. Not to frighten you away from a treatment that, accessed safely and appropriately, can be genuinely valuable for the right patient. But to help you understand why where you access it, and from whom, is not a minor detail. It is the detail.
From 25 years as a nurse, including six years in cardiac care at KIMS Hospital, I have a professional instinct for risk that doesn't switch off. What is happening in the counterfeit GLP-1 market right now registers as serious. Here is what the evidence actually shows.
What is actually in the grey market?
The term grey market covers a spectrum. At one end, it means legitimate-branded products sold without a prescription, without medical oversight, often sourced from countries where regulations differ. At the other end, it means deliberately counterfeit products: fake pens, fake packaging, and contents that have nothing to do with the drug on the label.
Both are dangerous. But the second category is the one that is hospitalising and killing people.
The MHRA, the UK's medicines regulator, has been escalating its enforcement response throughout 2025. In October 2025, in an operation called Operation Dunlin, agents raided a warehouse on an industrial estate in Northampton that turned out to be the first illicit weight loss drug production facility ever discovered on British soil and the largest single seizure of trafficked weight loss medicines ever recorded by any law enforcement agency globally. Inside were professional packaging machines, tens of thousands of empty injection pens, raw chemical ingredients, over 2,000 filled unlicensed pens ready for dispatch, and £20,000 in cash.
One of the drugs found, retatrutide, is still in Phase 3 clinical trials. It is not approved for use anywhere in the world. It was being packaged and sold to members of the public.
By February 2026, the MHRA had raided a second manufacturing network across sites in Lincolnshire and Nottinghamshire, seizing almost 2,000 further doses. Across 2025 as a whole, the agency seized nearly 20 million doses of illegally traded medicines worth almost £45 million and removed over 1,200 social media posts promoting illegal products. Andy Morling, Head of MHRA Criminal Enforcement, was direct: the message to those illegally trading in medicines could not be clearer. They are coming for them.
But enforcement, however determined, cannot keep pace with demand. That demand is being fuelled by limited NHS access, private prescription costs of £100 to £300 or more per pen, and a social media landscape saturated with offers that look far more accessible than they are.
What do counterfeit injections actually contain?
This is the question every patient considering a cheap online option needs to sit with.
The most dangerous contaminant identified in UK-seized counterfeit GLP-1 products is insulin. Fast-acting insulin injected into a person without diabetes can cause catastrophic hypoglycaemia, blood sugar so low the brain begins to shut down. This is what happened to Michelle Sword, 45, from Oxfordshire, who bought what she believed was an Ozempic pen on Facebook for £150. Within 20 minutes of injecting, she collapsed and began seizing in front of her 15-year-old daughter. Her blood sugar had fallen to 0.6 mmol/L. The normal range is 4 to 7. Hospital staff told her she was lucky to be alive.
In November 2025, an ITV investigation purchased pens from an international operation selling Raw branded tirzepatide via social media. Independent laboratory testing found the pens actually contained semaglutide, a completely different drug, at a concentration at least 20 times higher than the recommended starting dose. Professor Perdita Barran of the University of Manchester, who analysed the samples, was unambiguous: not only was it the wrong drug, it was at a quantity that could cause severe harm.
Beyond insulin and wrong-drug contamination, seized counterfeit GLP-1 products have been found to contain bacterial contamination from non-sterile manufacturing, no active ingredient at all, unapproved experimental compounds including retatrutide, and in international seizures, substances including antifreeze. The World Health Organisation issued a formal Medical Product Alert in June 2024 identifying falsified Ozempic batches in at least 16 countries. This is not a fringe problem.
How the grey market reaches your social media feed
Less than half of UK adults know that GLP-1 weight loss injections are prescription-only medicines. That knowledge gap is being deliberately exploited.
Facebook, Instagram, TikTok, WhatsApp, and Telegram are all actively used to market and sell counterfeit or unlicensed products. It is illegal in the UK to advertise any prescription medication, including through sponsored influencer content. That illegality has not slowed anyone down.
Beauty salons have emerged as a particularly serious distribution channel. Karen McGonigal's injections were offered by text message from a beautician. No medical history was taken. No skin was cleaned. No preparation of any kind. She trusted someone she knew and that trust was catastrophically misplaced.
DIY kits are also proliferating, powdered compound sold alongside syringes with instructions for home mixing and self-injection. The idea of an untrained person mixing a drug of unknown provenance and injecting it without any clinical context is, from a nursing perspective, genuinely alarming. In cardiac care I saw what happens when the wrong drug reaches the wrong patient at the wrong dose. It does not take long, and it does not always have a good outcome.
Santander UK research published in December 2025 found that almost £50,000 had been stolen from its customers by beauty scammers that year, with 68% of victims being women and the majority of scams originating on social media. That figure covers only Santander customers. The national total will be substantially higher and it captures only the financial loss, not the physical harm.
Eight red flags that should make you stop
The MHRA, the GPhC, and the WHO have all published guidance on identifying illegitimate products and providers. These are the warning signs that matter most.
No prescription required. GLP-1 medicines are prescription-only in the UK. Any seller offering them without one is operating illegally, full stop.
Prices that seem too good to be true. Genuine Mounjaro, Wegovy, or Ozempic costs £100 to £300 or more per pen from a registered pharmacy. A £20 injection at a salon is not a bargain. It is a warning.
Sold through social media or beauty salons. Facebook Marketplace, Instagram DMs, TikTok shops, and beauty therapists are not legitimate dispensing routes for prescription medicines.
No verifiable clinical credentials. The prescriber should appear on the GMC register if a doctor, or the NMC register if a nurse prescriber. The pharmacy should appear on the GPhC register. The clinic should be CQC-registered. These checks take minutes and could save your life.
Product arrives as powder in vials or in ordinary syringes. Genuine Wegovy, Mounjaro, and Ozempic come as pre-filled, pre-dosed injection pens. Vials requiring mixing are not legitimate branded products.
Cloudy, discoloured, or unusual-looking liquid. Legitimate semaglutide and tirzepatide solutions are clear, colourless, or very pale yellow. Cloudiness may indicate contamination, degradation, or a completely different substance.
Poor packaging, spelling errors, or missing information. The WHO has documented spelling mistakes on counterfeit Ozempic packaging. Legitimate products carry a UK product licence number, English-language patient information, tamper-evident seals, and consistent batch and expiry information.
No cold-chain delivery. GLP-1 injectable medicines require refrigeration at 2 to 8°C. A pen arriving in a standard postal envelope has not been stored appropriately and should not be used.
If you have already used a product you now have doubts about, please contact your GP immediately. Suspected fake medicines can be reported to the MHRA via the Yellow Card scheme or by calling the MHRA counterfeit hotline on 020 3080 6701.
A clinical note for patients on HRT
This section is for the many women in perimenopause or menopause who are considering GLP-1 therapy alongside hormone replacement therapy, because there is something your prescriber may not have mentioned.
Both semaglutide and tirzepatide slow gastric emptying as part of how they work. This affects the absorption of oral medications, including oral HRT. The British Menopause Society published formal guidance on this in April 2025, recommending that transdermal oestrogen, patches, gels, or sprays, is preferred for women on GLP-1 therapy because it bypasses the gut entirely and is unaffected by delayed gastric emptying. For the progestogen component, a non-oral route is similarly preferable, with the 52mg levonorgestrel IUD identified as the most comprehensive option.
If you are currently on oral HRT and considering a GLP-1 treatment, this is not a reason to avoid it. It is a reason to have a proper clinical conversation with someone who understands both and to review your HRT formulation before you start.
There is also genuinely encouraging emerging evidence. A 2024 Mayo Clinic study found that postmenopausal women on HRT who took semaglutide lost 16% of body weight at 12 months, compared to 12% in women not on HRT. A 2026 study published in The Lancet found that women combining tirzepatide with hormone therapy lost approximately 35% more total body weight than tirzepatide alone. The clinical picture is not that HRT and GLP-1s are incompatible. It is that they may work considerably better together, provided the HRT formulation is appropriate.
This is exactly the kind of integrated clinical thinking that a longevity medicine consultation provides and that a beauty salon or social media seller simply cannot.
How to access GLP-1 therapy safely in the UK
If you are considering weight loss injections and want to do it properly, here is what legitimate access looks like.
The prescriber must be registered with the GMC if a doctor, or the NMC if a nurse prescriber, with a V300 independent prescriber annotation. The dispensing pharmacy must appear on the GPhC register. The clinic must be CQC-registered if it is providing medical services including prescribing. You should receive a proper clinical assessment before any prescription is issued, not a two-minute online questionnaire.
From February 2025, GPhC rules require that online pharmacies cannot rely solely on self-reported information. Weight, height, and BMI must be independently verified. If a service doesn't do this, it is not compliant with current regulatory standards.
A legitimate provider will take a full medical history, discuss contraindications, explain the correct dosing schedule, and be available if something goes wrong. These are not optional extras. They are the minimum standard of care.
Before you buy anything
Karen McGonigal was 53. She wanted to feel better in her body. She found what looked like an accessible route to something she had heard could help, and she trusted the person offering it. The grey market for weight loss injections is not populated by people who look obviously untrustworthy. It is populated by people with professional-looking packaging, active social media accounts, and prices that feel reasonable. The Northampton operation described by the MHRA represented a level of sophistication they had not seen before in this space.
The most important thing I can say, as a nurse who has spent 25 years thinking about what happens when the body is put under stress it was not designed for: please do not inject yourself with something of unknown origin, at an unknown dose, administered by someone without the clinical training to manage what might happen next.
If you want to explore whether GLP-1 therapy is appropriate for you, as part of a properly assessed, medically supervised plan that considers your hormonal status, your metabolic picture, and your longer-term health, that is a conversation we can have properly at Juvenology.
Our Advanced Blood Panel gives us the clinical foundation to understand your metabolic health, inflammation, and hormonal picture before making any recommendations. Our longevity medicine approach means weight management is never considered in isolation from everything connected to it.
In cardiac nursing I watched what happens when the body receives the wrong drug, at the wrong dose, with no clinical safety net. What is happening in the grey market for weight loss injections is not a wellness industry problem. It is a patient safety crisis. And it is entirely preventable with the right information and the right clinical support.
About the author
Nurse Marina is the founder of Juvenology Clinic in Maidstone, Kent, with over 25 years of nursing experience including cardiac care at KIMS Hospital. She holds an EMSc in Longevity from the Geneva College of Longevity Science, a Longevity Medicine Intensive from NUS Yong Loo Lin School of Medicine in Singapore, and a qualification in Hormonal Health and Bioidentical Hormone Therapy from the Marion Gluck Academy. Marina is NMC Registered, JCCP Verified, BACN Member, ACE Group Registered, and a Member of the Royal College of Nursing.
From anti-wrinkle injections and dermal fillers to advanced regenerative treatments and longevity medicine, Marina combines rigorous medical knowledge with a nurturing, patient-centred approach.